1. Comparative effectiveness of extended-release naltrexone vs buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicenter, open label randomized control trial;Lee;Lancet,2018
2. The FODRAT study (Food addiction, Drugs, Alcohol and Tobacco): first data on food addiction prevalence among patients with addiction to drugs, tobacco and alcohol;Tinghino;Eat Weight Disorders,2021
3. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population;Morgan;J Subst Abuse Treat,2017
4. Alkermes Inc. Highlights of prescribing information: VIVITROL (naltrexone for extended-release injectable suspension). ; revised July 2013 [accessed 01.08.17].
5. Reckitt Benckiser Pharmaceuticals Inc. Highlights of prescribing information: SUBOXONE (buprenorphine and naloxone) sublingual film. ; revised August 2010 [accessed 01.08.17].